Skip to main content
. 2021 May;13(5):2705–2715. doi: 10.21037/jtd-21-178

Table 1. baseline characteristics.

Variables Study population No graft failure Graft failure P
Female (n, %) 29 (25.44) 11 (23.40) 18 (26.87) 0.676
Age (years) 61.82±8.53 63.60±9.12 60.58±7.92 0.063
Smoking (n, %) 65 (57.02) 26 (55.32) 39 (58.21) 0.759
Diabetes (n, %) 46 (40.35) 19 (40.43) 27 (40.30) 0.989
Hypertension (n, %) 74 (64.91) 32 (68.09) 42 (62.69) 0.552
Hyperlipemia (n, %) 81 (71.05) 32 (68.09) 49 (73.13) 0.558
Chronic renal insufficiency (n, %) 2 (1.75) 2 (4.26) 0 (0) 0.328
PVD (n, %) 5 (4.39) 1 (2.13) 4 (5.97) 0.602
Previous cerebrovascular accidents (n, %) 13 (11.40) 7 (14.89) 6 (8.96) 0.326
Previous MI (n, %) 30 (26.32) 14 (29.79) 16 (23.88) 0.481
Previous PCI (n, %) 19 (16.67) 7 (14.89) 12 (17.91) 0.671
Number of grafts 2.83±0.69 2.77±0.87 2.88±0.54 0.472
Follow time (month) 24.89±6.91 25.45±7.25 27.91±8.42 0.385

*, continuous variables with normal distribution are presented as mean ± SD unless otherwise noted. PVD, peripheral vascular disease; MI, myocardial infarction; PCI, percutaneous coronary intervention